Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile

  • Financials As Reported

    • accession Number 0001048477-23-000020
    • accounts Receivable Net Current 597,913,000
    • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 806,944,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --10,722,000
    • allocated Share Based Compensation Expense 53,695,000
    • amendment Flag false
    • assets 6,433,695,000
    • assets Current 2,842,105,000
    • cash And Cash Equivalents At Carrying Value 580,074,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 580,074,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --144,457,000
    • cik 1,048,477
    • city Area Code 415
    • common Stock Par Or Stated Value Per Share 0.001
    • common Stock Shares Authorized 500,000,000
    • common Stock Shares Issued 187,601,106
    • common Stock Shares Outstanding 187,601,106
    • comprehensive Income Net Of Tax 43,997,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-04-28
    • debt Instrument Carrying Amount 1,100,000,000
    • deferred Income Tax Expense Benefit --6,360,000
    • depreciation 10,300,000
    • depreciation Depletion And Amortization 26,421,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic 0.27
    • earnings Per Share Diluted 0.27
    • entity Address Address Line 1 770 Lindaro Street
    • entity Address City Or Town San Rafael
    • entity Address Postal Zip Code 94,901
    • entity Address State Or Province CA
    • entity Central Index Key 1,048,477
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 000-26727
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name BIOMARIN PHARMACEUTICAL INC
    • entity Registrant Name BioMarin Pharmaceutical Inc
    • entity Shell Company false
    • entity Small Business false
    • entity Tax Identification Number 68-0397820
    • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 56,757,000
    • income Tax Expense Benefit 5,905,000
    • increase Decrease In Accounts Receivable 138,796,000
    • increase Decrease In Inventories 14,098,000
    • increase Decrease In Other Operating Liabilities 4,262,000
    • interest Expense 3,703,000
    • interest Paid Net 1,437,000
    • inventory Net 918,921,000
    • irs Number 680,397,820
    • liabilities 1,774,652,000
    • liabilities And Stockholders Equity 6,433,695,000
    • liabilities Current 598,231,000
    • local Phone Number 506-6700
    • net Cash Provided By Used In Financing Activities --40,742,000
    • net Cash Provided By Used In Investing Activities --30,012,000
    • net Cash Provided By Used In Operating Activities --73,932,000
    • net Income Loss 50,852,000
    • operating Income Loss 59,347,000
    • other Assets Current 173,180,000
    • other Assets Noncurrent 150,057,000
    • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --6,855,000
    • other Liabilities Noncurrent 92,415,000
    • other Noncash Income Expense 222,000
    • payments Related To Tax Withholding For Share Based Compensation 51,422,000
    • payments To Acquire Property Plant And Equipment 24,456,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Gross 1,875,086,000
    • property Plant And Equipment Net 1,068,142,000
    • report Link https://www.sec.gov/Archives/edgar/data/1048477/000104847723000020/bmrn-20230331_htm.xml
    • research And Development Expense 171,846,000
    • retained Earnings Accumulated Deficit --738,347,000
    • revenue From Contract With Customer Excluding Assessed Tax 596,415,000
    • selling General And Administrative Expense 223,003,000
    • share Based Compensation 53,695,000
    • stockholders Equity 4,659,043,000
    • trading Symbol BMRN
    • update 1970-01-01
    • weighted Average Number Of Diluted Shares Outstanding 194,363,000
    • weighted Average Number Of Shares Outstanding Basic 186,667,000
    • id REPORTED_FINANCIALS
    • key BMRN
    • subkey 10-Q
    • date 2023-04-28
    • updated 2023-04-29
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

BMRN stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001048477-23-000020
  • accounts Receivable Net Current 597,913,000
  • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 806,944,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --10,722,000
  • allocated Share Based Compensation Expense 53,695,000
  • amendment Flag false
  • assets 6,433,695,000
  • assets Current 2,842,105,000
  • cash And Cash Equivalents At Carrying Value 580,074,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 580,074,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --144,457,000
  • cik 1,048,477
  • city Area Code 415
  • common Stock Par Or Stated Value Per Share 0.001
  • common Stock Shares Authorized 500,000,000
  • common Stock Shares Issued 187,601,106
  • common Stock Shares Outstanding 187,601,106
  • comprehensive Income Net Of Tax 43,997,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-04-28
  • debt Instrument Carrying Amount 1,100,000,000
  • deferred Income Tax Expense Benefit --6,360,000
  • depreciation 10,300,000
  • depreciation Depletion And Amortization 26,421,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic 0.27
  • earnings Per Share Diluted 0.27
  • entity Address Address Line 1 770 Lindaro Street
  • entity Address City Or Town San Rafael
  • entity Address Postal Zip Code 94,901
  • entity Address State Or Province CA
  • entity Central Index Key 1,048,477
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 000-26727
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name BIOMARIN PHARMACEUTICAL INC
  • entity Registrant Name BioMarin Pharmaceutical Inc
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 68-0397820
  • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 56,757,000
  • income Tax Expense Benefit 5,905,000
  • increase Decrease In Accounts Receivable 138,796,000
  • increase Decrease In Inventories 14,098,000
  • increase Decrease In Other Operating Liabilities 4,262,000
  • interest Expense 3,703,000
  • interest Paid Net 1,437,000
  • inventory Net 918,921,000
  • irs Number 680,397,820
  • liabilities 1,774,652,000
  • liabilities And Stockholders Equity 6,433,695,000
  • liabilities Current 598,231,000
  • local Phone Number 506-6700
  • net Cash Provided By Used In Financing Activities --40,742,000
  • net Cash Provided By Used In Investing Activities --30,012,000
  • net Cash Provided By Used In Operating Activities --73,932,000
  • net Income Loss 50,852,000
  • operating Income Loss 59,347,000
  • other Assets Current 173,180,000
  • other Assets Noncurrent 150,057,000
  • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --6,855,000
  • other Liabilities Noncurrent 92,415,000
  • other Noncash Income Expense 222,000
  • payments Related To Tax Withholding For Share Based Compensation 51,422,000
  • payments To Acquire Property Plant And Equipment 24,456,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Gross 1,875,086,000
  • property Plant And Equipment Net 1,068,142,000
  • report Link https://www.sec.gov/Archives/edgar/data/1048477/000104847723000020/bmrn-20230331_htm.xml
  • research And Development Expense 171,846,000
  • retained Earnings Accumulated Deficit --738,347,000
  • revenue From Contract With Customer Excluding Assessed Tax 596,415,000
  • selling General And Administrative Expense 223,003,000
  • share Based Compensation 53,695,000
  • stockholders Equity 4,659,043,000
  • trading Symbol BMRN
  • update 1970-01-01
  • weighted Average Number Of Diluted Shares Outstanding 194,363,000
  • weighted Average Number Of Shares Outstanding Basic 186,667,000
  • id REPORTED_FINANCIALS
  • key BMRN
  • subkey 10-Q
  • date 2023-04-28
  • updated 2023-04-29

Related News

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

TradingNEWS Archive 22.10.26
Stocks Markets AMZN MSFT NVDA META
META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

Itai Smidt 22.10.26
Stocks META PINS SNAP RDDT
S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

Itai Smidt 22.10.26
Stocks Markets IBM LRCX TSLA META
SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

Itai Smidt 21.10.26
Stocks Markets SMCI MU NVDA AMD
NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

Itai Smidt 21.10.26
Stocks NFLX WBD DIS AMZN
TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

Itai Smidt 21.10.26
Stocks TSLA GM F TM
Trade Now
© Trading News. All Rights Reserved Since 2022